CHICAGO – At the Ophthalmology Innovation Summit here, Amarpreet Sawhney, PhD, president and CEO of Ocular Therapeutix, discusses the company’s evaluation of sustained-release injectable anti-VEGF drug depots for posterior eye diseases. Ocular Therapeutix’s first product, ReSure Sealant, is now FDA-approved.
In a company-issued statement, Genentech responds to data regarding the DRCR.net Protocol T:Genentech thanks the Diabetic Retinopathy Clinical Research Network (DRCR.net) for bringing this important data to patients and physicians.The preliminary 1-year results of the DRCR.net Protocol T trial reinforce the safety and efficacy of Lucentis for diabetic macular edema (DME). The trial studied Lucentis 0.3 mg given less than monthly compared with other anti-VEGF agents in DME.
CHICAGO – IOP lowering through three different mechanisms comes together in one agent regardless of IOP baseline, a speaker said here at an Aerie Pharmaceuticals press briefing.Rhopressa relaxes the trabecular meshwork and increases outflow by inhibiting Rho kinase, lowers episcleral venous pressure, and reduces fluid production through inhibition of the norepinephrine transporter, Casey Kopczynski, PhD, said.
CHICAGO – PresbyLASIK with adaptive optics before surgery can provide asphericity and improve depth of focus, a speaker told colleagues here.“Visual outcomes after presbyLASIK can really be affected by different optical and [neurological] factors,” Pablo Artal, MD, PhD, said at Refractive Subspecialty Day preceding the American Academy of Ophthalmology meeting. “Adaptive optics, I believe, is a very powerful approach for presbyLASIK to really optimize the treatment before surgery.”
CHICAGO — The benefits of fixated IOLs outweigh the benefits of anterior chamber IOLs due to the increased risk for glaucoma, intraocular inflammation and corneal decompensation seen with anterior chamber IOLs, a surgeon postulated here in a debate of the issue.“We are comfortable with anterior chamber IOLs, and the surgery is simple and effective in our hands,” Jonathan L. Prenner, MD, said during a presentation at the Refractive Surgery Subspecialty Day preceding the American Academy of Ophthalmology meeting. “But, there’s no debate. AC-IOLs are macroincisional, they cause glaucoma, [cystoid macular (Read more...)
CHICAGO — Femtosecond laser-assisted cataract surgery has distinct upsides and downsides, according to two speakers who addressed colleagues here.Burkhard Dick, MD, PhD, and Michael E. Snyder, MD, debated the merits of laser refractive lens surgery during the Refractive Subspecialty Day preceding the American Academy of Ophthalmology meeting. Dick explained the procedure’s pros and Snyder described the cons.